000			03723nam a2200421 i 4500
999			_c362809 _d362809 _x1
001			362809
003			ES-MaUEC
005			20230102121619.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210927s2021 sz a s |||| 0|eng d
020			_a9783030801007
024	7		_a10.1007/978-3-030-80100-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM301.3.G45 _b2021 EB
100	1		_aHays, Priya _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9682237
245	1	0	_aAdvancing Healthcare Through Personalized Medicine _cby Priya Hays
250			_aSecond edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
264		4	_c2021
300			_a1 recurso en línea (XXV, 745 páginas) _b98 ilustraciones, 94 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_a1. Introduction: Biomedical Innovation and Policy in the Twenty-First Century -- 2. The Rise of Genomics and Personalized Medicine -- 3. Patient Narratives: Personalized Medicine in the Field -- 4. Alliances: Knowledge Infrastructures, and the Digitization of Precision Health -- 5. Tumor Genesis and Precision Oncology -- 6. Trends in Precision Oncology and Precision Medicine 2.0 -- 7.Personalized medicine's impact on disease -- 8. The Genome in the Clinic and Boardroom: Biomarkers, Diagnosis, Treatment, and Education -- 9. A New Set of Clinical tools for Physicians -- 10. Legislation, Reimbursement and the Regulatory Landscape -- 11. Translational personalized medicine: Molecular profiling, druggable targets, and clinical genomic medicine -- 12. The Health Economics of Personalized Precision Medicine -- 13. Moral, Societal and Ethical Issues: Claims, Consequences, and Caveats -- 14. Conclusion.
520			_aThis book provides a unique perspective on the biomedical and societal implications of personalized medicine and how it helps to mitigate the healthcare crisis and rein in ever-growing expenditure. It introduces the reader to the underlying concepts at the heart of personalized medicine. An innovative second edition, this book functions as an update to the successful first edition to include new, state-of-the-art information and advancements in the fast-paced field of personalized medicine. Chapters examine pharmacogenomics, targeted therapies, individualized diagnosis and treatment, and cancer immunotherapies. The book also features an essential discussion on how the advent of genomic technologies gives clinicians the capability to predict and diagnose disease more efficiently and offers a detailed up-to-date compilation of clinical trials in cancer leading to breakthrough therapies. The book also addresses the impact of Big Data on personalized medicine and the newfound applications of digital health and artificial intelligence. A work that advocates for a patient-centered approach, Advancing Healthcare Through Personalized Medicine, Second Edition is an invaluable text for clinicians, healthcare providers, and patients.
988			_aSpringer_Medicine_2021
650		7	_2embne _aFarmacología _9137893
650		7	_2embne _aGenética _9138044
776	0	8	_iPrinted edition: _z9783030800994
776	0	8	_iPrinted edition: _z9783030801014
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-80100-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _ek _zSI